Commission Implementing Regulation (EU) 2016/1085 of 5 July 2016 approving Bacillus amyloliquefaciens strain ISB06 as an existing active substance for use in biocidal products of product-type 3
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
180/2016
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2016/1085 of 5 July 2016 approving Bacillus amyloliquefaciens strain ISB06 as an existing active substance for use in biocidal products of product-type 3
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2016/1085 frá 5. júlí 2016 um að samþykkja Bacillus amyloliquefaciens af stofni ISB06 sem fyrirliggjandi virkt efni til notkunar í sæfivörur í vöruflokki 3
Durchführungsverordnung (EU) 2016/1085 der Kommission vom 5. Juli 2016 zur Genehmigung von Bacillus amyloliquefaciens Stamm ISB06 als alten Wirkstoff zur Verwendung in Biozidprodukten der Produktart 3
Kommisjonens gjennomføringsforordning (EU) 2016/1085 av 5. juli 2016 om godkjenning av Bacillus amyloliquefaciens stamme ISB06 som eksisterende aktivt stoff til bruk i biocidprodukter av type 3
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.